These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3872638)

  • 1. Reduced opsonisation of protein A containing Staphylococcus aureus in sera with cryoglobulins from patients with active systemic lupus erythematosus.
    Nived O; Linder C; Odeberg H; Svensson B
    Ann Rheum Dis; 1985 Apr; 44(4):252-9. PubMed ID: 3872638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
    Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
    Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.
    Erhardt CC; Mumford P; Maini RN
    Ann Rheum Dis; 1984 Jun; 43(3):451-6. PubMed ID: 6611139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
    Sturfelt G; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypocomplementemia with low C1s-C1 inhibitor complex in systemic lupus erythematosus.
    Lockshin MD; Qamar T; Redecha P; Harpel PC
    Arthritis Rheum; 1986 Dec; 29(12):1467-72. PubMed ID: 3492208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q and immune complexes in liver cirrhosis sera.
    Yoshida H; Sato M; Watanabe S; Nishimaki T; Morito T; Kasukawa R; Nakai M
    Tohoku J Exp Med; 1983 May; 140(1):73-9. PubMed ID: 6603034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-mediated solubilization of immune complexes. Solubilization inhibition and complement factor levels in SLE patients.
    Baatrup G; Petersen I; Kappelgaard E; Jepsen HH; Svehag SE
    Clin Exp Immunol; 1984 Feb; 55(2):313-8. PubMed ID: 6230182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
    Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG; Redecha PB; Kimberly RP; Christian CL
    J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
    Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
    Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus.
    Abramson SB; Given WP; Edelson HS; Weissmann G
    Arthritis Rheum; 1983 May; 26(5):630-6. PubMed ID: 6847725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of complement measurements in the assessment of lupus activity.
    Milis L; Timmermans V; Morris CA; Pussell BA; Charlesworth JA
    Aust N Z J Med; 1992 Aug; 22(4):338-44. PubMed ID: 1445021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.